title: [National trend of management of benign prostatic hyperplasia in Japan during 1990s: analysis of national health statistics].
abstract: To review the contemporary management of benign prostatic hyperplasia (BPH) in Japan during 1990s, we analyzed several nationwide health statistics by the Ministry of Health and Welfare of Japan. The cross-sectional surveys revealed that the estimated total number of patients receiving treatment increased from 202,000 in 1987, to 335,000 and 590,000, respectively, in 1995 and 1998. Approximately 73-80% of patients were men aged 65 years or over and 94-98% 55 years or older. Urologists treated two thirds of the BPH patients. The incidence of prostatectomies remained relatively stable at 50,000/year (3.0-3.8 prostatectomies/1,000 men aged 55 or over). The average hospital stay in 1996 was 24.7 days. The total cost of BPH therapy nearly doubled between 1988 and 1998. The ratio of outpatient to inpatient costs ranged from 1.5 to 2.2 and 60% of the outpatient cost was spent for medical therapy. The total value of the market for medical therapy increased from 30-40 billion yen in 1989 to more than 80 billion yen in 1998. The application of alpha-blockers increased from 243,000 men (70% of all patients) in 1995 to 452,000 (77%) in 1998, whereas the number of patients taking antiandrogens, plant extracts and antispasmodic agents/Ca antagonists (for pollakisuria), respectively, remained relatively stable at 60,000-70,000, 180,000 and 300,000. Because Japan is a rapidly aging society and men aged 55 or older are expected to increase from 15 million in 1995 to 21 million in 2010, cost-effective treatment guidelines for the Japanese BPH patients are needed.
authors.affiliation: Department of Urology, Graduate School of Medicine, Kyoto University.
authors.forename: A
authors.initials: A
authors.lastname: Terai
authors.forename: Y
authors.initials: Y
authors.lastname: Kakehi
authors.forename: T
authors.initials: T
authors.lastname: Terachi
authors.forename: O
authors.initials: O
authors.lastname: Ogawa
mesh_terms: D000368:Aged; D003362:Cost-Benefit Analysis; D006306:Health Surveys; D006801:Humans; D007564:Japan; D007902:Length of Stay; D008297:Male; D008875:Middle Aged; D011468:Prostatectomy / Q000706:statistics & numerical data; D011470:Prostatic Hyperplasia / Q000188:drug therapy / Q000191:economics / Q000628:therapy*